Bridgefront Capital’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,908	Closed	-$312K	–	627
2024 Q3	$312K	Buy	+5,908	New	+$312K	0.12%	305
2024 Q2	–	Sell	-5,691	Closed	-$399K	–	518
2024 Q1	$399K	Buy	+5,691	New	+$399K	0.3%	114